RegeneRx Biopharmaceuticals is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding RegeneRx's performance made by these analysts are theirs alone and do not necessarily represent opinions, forecasts or predictions by RegeneRx Biopharmaceuticals or its management.
| Freeman Dong | SeeThruEquity, LLC | Coverage Initiated July 8, 2015 | freeman@seethruequity.com |
| Ajay Tandon | SeeThruEquity, LLC | Coverage Updated October 28, 2015 | ajay@seethruequity.com |
| Raghuram Selvaraju, Ph.D. | Rodman & Renshaw | Coverage Initiated March 14, 2016 | rselvaraju@rodm.com |
| Yi Chen, Ph.D., CFA | Rodman & Renshaw | Coverage Initiated March 14, 2016 | ychen@rodm.com |